What is BDSX's market cap?

Biodesix, Inc. (BDSX) is a listed stock with a live quote. The latest market cap on this page is $170M.

Where is Biodesix, Inc. headquartered?

Biodesix, Inc. is headquartered in Boulder, CO.

How do I get BDSX news from the API?

Call GET /v1/news?tickers=BDSX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

How far back does BDSX news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for BDSX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.

Is the BDSX price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Can I use the Pro plan commercially?

No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email sales@marketnewsapi.com.

BDSX · NASDAQ

Biodesix, Inc.

$20.88 0.00 (0.00%)

Company overview

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of the Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help identify the appropriate treatment pathway. These tests also assist physicians in reclassifying malignancy risk in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish prognosis and help guide treatment decisions, as well as the GeneStrat NGS test, a 72-hour blood-based next-generation sequencing test.

Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: NASDAQ
Market cap: $170M
Employees: 273
Headquarters: Boulder, CO
Website: biodesix.com
CEO: Scott Hutton
Listed: October 28, 2020
P/E: -5.14
Dividend yield: 0.00%

Company financials

Revenue: $96.1M
Gross profit: $78.9M
Operating income: -$24.9M
EBITDA: -$18.3M
Net income: -$32M
EPS: -$4.06
Total assets: $94.6M
Total debt: $71.6M
Gross margin: 82.08%
Net margin: -33.26%
Earnings yield: -19.44%

Revenue segmentation

By product (FY 2025)

By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

BDSX 1D NASDAQ O21.80H22.89L20.74C20.88-0.90 (-4.13%)Vol24.74K

News

Ticker	Type	Headline	Source	Published
BDSXBiodesix, Inc.	Press release	Biodesix to Participate in Upcoming Investor Conferences	GlobeNewswire	Nov 4, 6:00:05 AM ET
BDSXBiodesix, Inc.	Stock news	All You Need to Know About Biodesix (BDSX) Rating Upgrade to Buy	Zacks Investment Research	Oct 29, 1:01:02 PM ET
BDSXBiodesix, Inc.	Stock news	Will Biodesix, Inc. (BDSX) Report Negative Earnings Next Week? What You Should Know	Zacks Investment Research	Oct 29, 11:06:51 AM ET
BDSXBiodesix, Inc.	Press release	Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026	GlobeNewswire	Oct 22, 6:00:00 AM ET
BDSXBiodesix, Inc.	Press release	American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification	GlobeNewswire	Oct 19, 4:01:00 PM ET
BDSXBiodesix, Inc.	Press release	Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers	GlobeNewswire	Oct 19, 6:00:00 AM ET
BDSXBiodesix, Inc.	Press release	Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026	GlobeNewswire	Oct 13, 6:00:00 AM ET
BDSXBiodesix, Inc.	Stock news	Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests	Zacks Investment Research	Sep 28, 12:05:56 PM ET
BDSXBiodesix, Inc.	Press release	Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring	GlobeNewswire	Sep 24, 6:00:00 AM ET
BDSXBiodesix, Inc.	Press release	Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings	GlobeNewswire	Sep 14, 4:01:00 PM ET
BDSXBiodesix, Inc.	Stock news	Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of “Moderate Buy” by Analysts	Defense World	Sep 7, 4:49:58 AM ET
BDSXBiodesix, Inc.	Press release	Biodesix to Participate in Upcoming Investor Conferences	GlobeNewswire	Sep 3, 6:00:00 AM ET
BDSXBiodesix, Inc.	Stock news	What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?	Zacks Investment Research	Aug 31, 1:01:08 PM ET
BDSXBiodesix, Inc.	Stock news	Wall Street Analysts See a 26.72% Upside in Biodesix (BDSX): Can the Stock Really Move This High?	Zacks Investment Research	Aug 31, 10:56:05 AM ET
BDSXBiodesix, Inc.	Stock news	PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?	Zacks Investment Research	Aug 24, 1:41:07 PM ET
BDSXBiodesix, Inc.	Stock news	Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference	MarketBeat	Aug 12, 5:05:48 PM ET
BDSXBiodesix, Inc.	Stock news	Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year?	Zacks Investment Research	Aug 12, 10:41:34 AM ET
BDSXBiodesix, Inc.	Stock news	Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?	Zacks Investment Research	Aug 11, 10:16:11 AM ET
BDSXBiodesix, Inc.	Stock news	Wall Street Analysts Think Biodesix (BDSX) Could Surge 31.91%: Read This Before Placing a Bet	Zacks Investment Research	Aug 10, 10:57:14 AM ET
BDSXBiodesix, Inc.	Stock news	Biodesix, Inc. (BDSX) Q2 2026 Earnings Call Transcript	Seeking Alpha	Aug 6, 7:20:22 AM ET

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.